XML 51 R34.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY AND NONCONTROLLING INTERESTS (Tables)
6 Months Ended
Jun. 27, 2020
Equity [Abstract]  
Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
Three Months EndedSix Months Ended
June 27, 2020June 29, 2019June 27, 2020June 29, 2019
(in thousands)
Numerator:  
Net income$67,668  $44,309  $118,505  $99,997  
Less: Net income attributable to noncontrolling interests233  581  301  1,136  
Net income attributable to common shareholders$67,435  $43,728  $118,204  $98,861  
Denominator:  
Weighted-average shares outstanding - Basic49,553  48,772  49,371  48,615  
Effect of dilutive securities:
Stock options, restricted stock units and performance share units693  890  747  984  
Weighted-average shares outstanding - Diluted50,246  49,662  50,118  49,599  
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
Foreign Currency Translation Adjustment
and Other
Pension and Other Post-Retirement Benefit PlansTotal
(in thousands)
December 28, 2019$(87,578) $(90,441) $(178,019) 
Other comprehensive loss before reclassifications(37,611) —  (37,611) 
Amounts reclassified from accumulated other comprehensive loss—  2,739  2,739  
Net current period other comprehensive income (loss)(37,611) 2,739  (34,872) 
Income tax expense (benefit)(761) 584  (177) 
June 27, 2020$(124,428) $(88,286) $(212,714) 
Rollforward Redeemable Noncontrolling Interest
The following table provides a rollforward of the activity related to the Company’s redeemable noncontrolling interests:
Six Months Ended
June 27, 2020June 29, 2019
(in thousands)
Beginning balance$28,647  $18,525  
Acquisition of noncontrolling interest(3,732) —  
Adjustment to Vital River redemption value (three months ended March 30, 2019)—  1,451  
Purchase of Vital River 5% equity interest
—  (8,745) 
Change in fair value of Vital River 8% equity interest, included in additional-paid-in-capital
—  2,708  
Modification of Vital River 8% purchase option
—  2,196  
Acquisition of a 10% non-controlling interest through acquiring Citoxlab
—  4,095  
Net (loss) income attributable to noncontrolling interests(538) 284  
Foreign currency translation(493) (35) 
Ending balance$23,884  $20,479